Omvoh 00002-8870

Generic: Mirikizumab-Mrkz

Product NDC

00002-8870

Manufacturer: Eli Lilly And Company
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: April 29, 2024
Listing Expires: December 31, 2026
Application: BLA761279

Need to source Omvoh? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Mirikizumab	100 mg/mL

Drug Class

Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]

Packaging Options(1)

00002-8870-27

2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01)

View →